NASDAQ:COHR - Coherent Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $169.00
  • Forecasted Upside: -17.14 %
  • Number of Analysts: 10
  • Breakdown:
  • 0 Sell Ratings
  • 6 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$203.96
▼ -0.7 (-0.34%)
1 month | 3 months | 12 months
Get New Coherent Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for COHR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for COHR

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$169.00
▼ -17.14% Downside Potential
This price target is based on 10 analysts offering 12 month price targets for Coherent in the last 3 months. The average price target is $169.00, with a high forecast of $215.00 and a low forecast of $140.00. The average price target represents a -17.14% upside from the last price of $203.96.
Hold
The current consensus among 10 investment analysts is to hold stock in Coherent. This rating has held steady since November 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 3 buy ratings
  • 7 hold ratings
  • 0 sell ratings
8/5/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 6 hold ratings
  • 0 sell ratings
11/3/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/1/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/1/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/30/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 0 sell ratings
10/28/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
12/27/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 6 hold ratings
  • 0 sell ratings
1/26/2021

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 6 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/21/2021Berenberg BankDowngradeBuy ➝ Hold$215.00Medium
i
1/20/2021BarclaysUpgradeUnderweight ➝ Equal WeightLow
i
1/12/2021BarclaysDowngradeEqual Weight ➝ Underweight$125.00 ➝ $140.00High
i
11/12/2020Longbow ResearchDowngradeBuy ➝ NeutralHigh
i
11/11/2020Stifel NicolausDowngradeBuy ➝ HoldHigh
i
9/14/2020Vertical ResearchUpgradeSell ➝ NeutralLow
i
8/5/2020BenchmarkLower Price TargetBuy$168.00 ➝ $160.00High
i
8/5/2020Needham & Company LLCReiterated RatingHoldHigh
i
Rating by James Ricchiuti at Needham & Company LLC
7/27/2020Longbow ResearchUpgradeNeutral ➝ Buy$165.00High
i
5/29/2020140166Reiterated RatingBuy$170.00Low
i
Rating by Mehdi Hosseini at 140166
5/28/2020Needham & Company LLCInitiated CoverageHoldHigh
i
Rating by James Ricchiuti at Needham & Company LLC
5/28/2020Stifel NicolausLower Price TargetBuy$178.00 ➝ $170.00High
i
5/28/2020BenchmarkLower Price TargetBuy$175.00 ➝ $168.00High
i
5/28/2020Piper SandlerLower Price TargetOverweight$195.00 ➝ $185.00High
i
4/24/2020The Goldman Sachs GroupUpgradeNeutral ➝ Buy$154.00 ➝ $147.00High
i
Rating by Brian K. Lee at The Goldman Sachs Group, Inc.
4/17/2020BarclaysLower Price TargetEqual Weight$160.00 ➝ $130.00Low
i
4/13/2020BenchmarkReiterated RatingBuyLow
i
2/10/2020Stifel NicolausReiterated RatingBuy$178.00Low
i
2/6/2020Piper SandlerLower Price Target$205.00 ➝ $195.00Medium
i
2/6/2020BarclaysLower Price TargetEqual Weight$170.00 ➝ $160.00Medium
i
2/6/2020140166Reiterated RatingBuy$195.00Medium
i
Rating by Mehdi Hosseini at 140166
2/6/2020BenchmarkReiterated RatingBuy$175.00Medium
i
1/19/2020BarclaysReiterated RatingHold$170.00Medium
i
12/20/2019Piper Jaffray CompaniesInitiated CoverageOverweight$205.00High
i
12/16/2019140166UpgradeNeutral ➝ Positive$130.00 ➝ $200.00High
i
Rating by Mehdi Hosseini at 140166
11/27/2019140166Reiterated RatingHoldLow
i
Rating by Mehdi Hosseini at 140166
11/6/2019BenchmarkBoost Price TargetBuy$175.00 ➝ $182.00Low
i
9/17/2019BenchmarkBoost Price TargetBuy$165.00 ➝ $175.00Low
i
7/31/2019BenchmarkReiterated RatingBuy$165.00High
i
5/1/2019Stifel NicolausBoost Price TargetBuy ➝ Buy$165.00 ➝ $174.00Medium
i
4/29/2019140166DowngradePositive ➝ Neutral$140.00High
i
1/30/2019BenchmarkReiterated RatingBuy$212.00 ➝ $162.00High
i
1/30/2019Needham & Company LLCDowngradeBuy ➝ HoldHigh
i
1/29/2019Northcoast ResearchReiterated RatingHoldMedium
i
Rating by Tom Hayes at Northcoast Research
1/17/2019BarclaysDowngradeOverweight ➝ Equal Weight$162.00 ➝ $125.00Medium
i
Rating by Joseph Wolf at Barclays PLC
12/10/2018The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$136.00Medium
i
11/27/2018Vertical ResearchInitiated CoverageBuyMedium
i
11/19/2018Northcoast ResearchReiterated RatingHoldLow
i
Rating by Tom Hayes at Northcoast Research
11/14/2018Berenberg BankInitiated CoverageBuyMedium
i
11/7/2018BenchmarkLower Price TargetBuy$216.00 ➝ $212.00Medium
i
10/24/2018Northcoast ResearchReiterated RatingHoldHigh
i
Rating by Tom Hayes at Northcoast Research
10/23/2018Stifel NicolausSet Price TargetBuy$185.00High
i
Rating by Patrick Ho at Stifel Nicolaus
10/23/2018BarclaysLower Price TargetOverweight ➝ Buy$218.00 ➝ $170.00High
i
Rating by Joseph Wolf at Barclays PLC
10/9/2018Longbow ResearchDowngradeBuy ➝ NeutralHigh
i
Rating by Joe Wittine at Longbow Research
10/8/2018Northcoast ResearchDowngradeBuy ➝ HoldMedium
i
9/13/2018BenchmarkReiterated RatingBuy$216.00Low
i
8/23/2018Longbow ResearchSet Price TargetBuy$215.00Low
i
Rating by Joe Wittine at Longbow Research
8/2/2018Northcoast ResearchReiterated RatingBuy$217.00Low
i
8/1/2018Needham & Company LLCLower Price TargetBuy$205.00 ➝ $190.00High
i
8/1/2018BenchmarkReiterated RatingBuy$242.00 ➝ $216.00High
i
7/27/2018Stifel NicolausLower Price TargetBuy ➝ Buy$218.00 ➝ $214.00Low
i
6/12/2018BenchmarkReiterated RatingBuy$242.00Medium
i
6/12/2018Needham & Company LLCLower Price TargetBuy$250.00 ➝ $205.00Medium
i
5/10/2018Stifel NicolausInitiated CoverageBuy ➝ Buy$248.00Low
i
5/2/2018Needham & Company LLCLower Price TargetBuy$250.00High
i
5/2/2018BenchmarkReiterated RatingBuy ➝ Buy$310.00 ➝ $275.00High
i
5/2/2018BarclaysLower Price TargetOverweight ➝ Buy$225.00 ➝ $218.00High
i
Rating by Joseph Wolf at Barclays PLC
4/12/2018BarclaysReiterated RatingBuy$225.00Medium
i
Rating by Joseph Wolf at Barclays PLC
4/9/2018BenchmarkReiterated RatingBuy$310.00Low
i
2/12/2018Northcoast ResearchReiterated RatingBuy$314.00Low
i
2/8/2018BarclaysSet Price TargetOverweight ➝ Overweight$332.00 ➝ $325.00High
i
Rating by Joseph Wolf at Barclays PLC
2/8/2018Stifel NicolausLower Price TargetBuy ➝ Buy$330.00 ➝ $310.00High
i
2/8/2018Needham & Company LLCReiterated RatingBuy ➝ Buy$330.00 ➝ $294.00High
i
1/10/2018BarclaysSet Price TargetBuy$332.00Low
i
Rating by Joseph Wolf at Barclays PLC
11/8/2017BarclaysBoost Price TargetOverweight$285.00 ➝ $315.00N/A
i
11/8/2017Stifel NicolausBoost Price TargetBuy$290.00 ➝ $330.00N/A
i
11/8/2017BenchmarkBoost Price TargetBuy$290.00 ➝ $310.00N/A
i
11/8/2017Needham & Company LLCBoost Price TargetBuy$270.00 ➝ $330.00N/A
i
10/12/2017BenchmarkReiterated RatingBuy$290.00N/A
i
9/23/2017Summit RedstoneReiterated RatingBuy$320.00Medium
i
9/13/2017Stifel NicolausReiterated RatingBuy$290.00Medium
i
9/12/2017Northcoast ResearchReiterated RatingBuy$311.00 ➝ $314.00Medium
i
9/5/2017140166Reiterated RatingPositive$275.00Medium
i
8/8/2017BenchmarkReiterated RatingBuy$295.00 ➝ $290.00Low
i
8/7/2017BarclaysInitiated CoverageOverweight ➝ Overweight$285.00Medium
i
8/3/2017140166UpgradeNeutral ➝ Positive$255.00 ➝ $275.00Low
i
8/3/2017UBS GroupUpgradeNeutral ➝ PositiveMedium
i
8/2/2017Needham & Company LLCReiterated RatingBuy$265.00 ➝ $270.00Medium
i
8/2/2017BenchmarkReiterated RatingBuy ➝ Buy$295.00 ➝ $290.00High
i
7/20/2017BenchmarkReiterated RatingBuy ➝ Buy$275.00 ➝ $295.00Low
i
6/30/2017140166Reiterated RatingNeutral$240.00 ➝ $255.00Low
i
6/30/2017Stifel NicolausReiterated RatingBuy ➝ Buy$270.00 ➝ $290.00Medium
i
6/28/2017Longbow ResearchReiterated RatingBuy$325.00Low
i
Rating by Joe Wittine at Longbow Research
6/12/2017Longbow ResearchReiterated RatingNeutral ➝ Buy$325.00High
i
5/10/2017140166Reiterated RatingNeutral$225.00 ➝ $240.00Low
i
5/10/2017Needham & Company LLCBoost Price TargetBuy ➝ Buy$215.00 ➝ $265.00High
i
5/10/2017Stifel NicolausBoost Price TargetBuy ➝ Buy$220.00 ➝ $270.00High
i
5/10/2017BenchmarkReiterated RatingBuyHigh
i
3/13/2017Needham & Company LLCBoost Price TargetBuy ➝ Buy$215.00High
i
2/15/2017140166Initiated CoverageNeutral$225.00N/A
i
2/14/2017UBS GroupInitiated CoverageNeutralN/A
i
2/8/2017Needham & Company LLCReiterated RatingBuy$145.00 ➝ $205.00N/A
i
1/9/2017Stifel NicolausBoost Price TargetBuy$145.00 ➝ $170.00N/A
i
1/3/2017Stifel NicolausBoost Price TargetBuy$135.00 ➝ $145.00N/A
i
12/28/2016BenchmarkBoost Price TargetBuy$125.00 ➝ $160.00N/A
i
11/14/2016Needham & Company LLCReiterated RatingBuy$130.00 ➝ $145.00N/A
i
11/10/2016BenchmarkReiterated RatingBuy$112.00 ➝ $125.00N/A
i
11/3/2016Needham & Company LLCBoost Price TargetBuy$115.00 ➝ $130.00N/A
i
Rating by James Ricchiuti at Needham & Company LLC
10/25/2016Northcoast ResearchInitiated CoverageBuy$130.00N/A
i
7/28/2016BenchmarkLower Price TargetBuy$115.00 ➝ $112.00N/A
i
7/28/2016Stifel NicolausBoost Price TargetBuy$115.00 ➝ $120.00N/A
i
Rating by Patrick Newton at Stifel Nicolaus
5/23/2016BenchmarkBoost Price TargetBuy$110.00 ➝ $115.00N/A
i
5/17/2016Needham & Company LLCReiterated RatingBuyN/A
i
Rating by James Ricchiuti at Needham & Company LLC
3/22/2016B. RileyReiterated RatingNeutral$70.00N/A
i
Rating by Dave Kang at B. Riley
3/17/2016B. RileyReiterated RatingNeutral$70.00N/A
i
Rating by Dave Kang at B. Riley
3/17/2016Needham & Company LLCBoost Price TargetBuy$85.00 ➝ $95.00N/A
i
Rating by James Ricchiuti at Needham & Company LLC
1/31/2016B. RileyReiterated RatingNeutral$70.00N/A
i
Rating by Dave Kang at B. Riley
1/29/2016Needham & Company LLCReiterated RatingBuy$68.00 ➝ $85.00N/A
i
Rating by James Ricchiuti at Needham & Company LLC
1/29/2016Stifel NicolausBoost Price TargetBuy$72.00 ➝ $82.00N/A
i
(Data available from 1/27/2016 forward)
Coherent logo
Coherent, Inc. provides lasers, laser-based technologies, and laser-based system solutions for a range of scientific, commercial, and industrial research applications. It operates in two segments, OEM Laser Sources and Industrial Lasers & Systems. The company designs, manufactures, markets, and services lasers, laser tools, precision optics, and related accessories; and laser measurement and control products. Its products are used for applications in microelectronics, materials processing, original equipment manufacturer components and instrumentation, and scientific research and government programs. The company markets its products through a direct sales force in the United States, as well as through direct sales personnel and independent representatives internationally. Coherent, Inc. was founded in 1966 and is headquartered in Santa Clara, California.
Read More

Today's Range

Now: $203.96
$203.18
$206.40

50 Day Range

MA: $158.16
$135.61
$205.31

52 Week Range

Now: $203.96
$78.21
$213.05

Volume

307,825 shs

Average Volume

724,808 shs

Market Capitalization

$4.98 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.54

Frequently Asked Questions

What sell-side analysts currently cover shares of Coherent?

The following equities research analysts have issued research reports on Coherent in the last year: 140166, Barclays PLC, Benchmark Co., Berenberg Bank, Longbow Research, Needham & Company LLC, Piper Sandler, Stifel Nicolaus, The Goldman Sachs Group, Inc., TheStreet, Vertical Research, and Zacks Investment Research.

What is the current price target for Coherent?

8 Wall Street analysts have set twelve-month price targets for Coherent in the last year. Their average twelve-month price target is $169.00, suggesting a possible downside of 17.4%. Berenberg Bank has the highest price target set, predicting COHR will reach $215.00 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of $140.00 for Coherent in the next year.

What is the current consensus analyst rating for Coherent?

Coherent currently has 6 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in COHR, but not buy more shares or sell existing shares.

What other companies compete with Coherent?

How do I contact Coherent's investor relations team?

Coherent's physical mailing address is 5100 Patrick Henry Drive, Santa Clara CA, 95054. The scientific and technical instruments company's listed phone number is 408-764-4000 and its investor relations email address is [email protected] The official website for Coherent is www.coherent.com.